117 related articles for article (PubMed ID: 15919504)
21. Development of lymphoproliferative disease after liver transplantation.
Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
[TBL] [Abstract][Full Text] [Related]
22. Symptomatic osteonecrosis of the femoral head after adult orthotopic liver transplantation.
Li H; Zhang J; He JW; Wang K; Wang GS; Jiang N; Fu BS; Wang GY; Yang Y; Chen GH
Chin Med J (Engl); 2012 Jul; 125(14):2422-6. PubMed ID: 22882914
[TBL] [Abstract][Full Text] [Related]
23. Renal function in pediatric liver transplantation: a long-term follow-up study.
Harambat J; Ranchin B; Dubourg L; Liutkus A; Hadj-Haïssa A; Rivet C; Boillot O; Lachaux A; Cochat P
Transplantation; 2008 Oct; 86(8):1028-34. PubMed ID: 18946339
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors of development of lung tumors after liver transplantation.
Jiménez C; Marqués E; Manrique A; Loinaz C; Gómez R; Meneu JC; Abradelo M; Pérez B; Moreno A; García I; Moreno E
Transplant Proc; 2005 Nov; 37(9):3970-2. PubMed ID: 16386600
[TBL] [Abstract][Full Text] [Related]
25. A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation.
Zaghla H; Selby RR; Chan LS; Kahn JA; Donovan JA; Jabbour N; Genyk Y; Mateo R; Gagandeep S; Sher LS; Ramicone E; Fong TL
Aliment Pharmacol Ther; 2006 Feb; 23(4):513-20. PubMed ID: 16441472
[TBL] [Abstract][Full Text] [Related]
26. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
[TBL] [Abstract][Full Text] [Related]
27. Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients.
Morard I; Dumortier J; Spahr L; Hadengue A; Majno P; Morel P; Mentha G; Giostra E
Liver Transpl; 2007 May; 13(5):658-64. PubMed ID: 17457887
[TBL] [Abstract][Full Text] [Related]
28. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
[TBL] [Abstract][Full Text] [Related]
29. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
Jensen GS; Wiseman A; Trotter JF
Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
[No Abstract] [Full Text] [Related]
30. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
[TBL] [Abstract][Full Text] [Related]
31. Plasma exchange therapy for thrombotic thrombocytopenic purpura in pediatric patients with liver transplantation.
Lee CH; Chen CL; Lin CC; Yang CH; Cheng YF; Wang MC; Eng HL; Liu PP; Chuang FR
Transplant Proc; 2008 Oct; 40(8):2554-6. PubMed ID: 18929799
[TBL] [Abstract][Full Text] [Related]
32. Tacrolimus-related seizure in the early postoperative period after liver transplantation.
Sevmis S; Karakayali H; Emiroglu R; Akkoc H; Haberal M
Transplant Proc; 2007 May; 39(4):1211-3. PubMed ID: 17524935
[TBL] [Abstract][Full Text] [Related]
33. Results of pediatric liver transplantation in an originally adult liver transplant program.
Pirenne J; Aerts R; Monbaliu D; Coosemans W; Vlasselaers D; Desmet L; Herman J; Hoffman I; Lombaerts R
Transplant Proc; 2007 Oct; 39(8):2672-4. PubMed ID: 17954204
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
[TBL] [Abstract][Full Text] [Related]
35. Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation.
Bianchi G; Nicolino F; Passerini G; Grazi GL; Zappoli P; Graziani R; Berzigotti A; Chianese R; Mantovani V; Pinna AD; Zoli M
Liver Transpl; 2006 Jan; 12(1):105-11. PubMed ID: 16382457
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study.
Saliba F; Lakehal M; Pageaux GP; Roche B; Vanlemmens C; Duvoux C; Dumortier J; Salamé E; Calmus Y; Maugendre D;
Liver Transpl; 2007 Jan; 13(1):136-44. PubMed ID: 17192854
[TBL] [Abstract][Full Text] [Related]
37. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
Hoitsma AJ; Hilbrands LB
Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
[TBL] [Abstract][Full Text] [Related]
38. Diabetes mellitus after kidney transplantation: a French multicentre observational study.
Kamar N; Mariat C; Delahousse M; Dantal J; Al Najjar A; Cassuto E; Lefrançois N; Cointault O; Touchard G; Villemain F; Di Giambattista F; Benhamou PY;
Nephrol Dial Transplant; 2007 Jul; 22(7):1986-93. PubMed ID: 17400559
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism.
Guichelaar MM; Malinchoc M; Sibonga J; Clarke BL; Hay JE
Liver Transpl; 2004 May; 10(5):638-47. PubMed ID: 15108255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
